iBio (IBIO) Inventory Average (2021 - 2022)

iBio (IBIO) posted quarterly Inventory Average of $3.6 million for Q2 2022, up 36.33% quarter-over-quarter from $2.6 million in Q1 2022.

iBio (IBIO) Inventory Average (2021 - 2022) Analysis & Trends

iBio (IBIO) has reported Inventory Average for 2 consecutive years, with $3.6 million the latest figure, recorded in Q2 2022.

In Q2 2022, Inventory Average changed N/A year-over-year to $3.6 million; the TTM figure through Jun 2022 stood at $3.6 million (changed N/A YoY), while the FY2022 annual figure was $2.0 million, changed N/A from the prior year.
Inventory Average rose to $3.6 million in Q2 2022 per IBIO's latest filing, from $2.6 million in the prior quarter.
Across five years, Inventory Average topped out at $3.6 million in Q2 2022 and bottomed at $307000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	213.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	707.10 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	90.57 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	137.65 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	196.36 Mn
10	iBio	175.21 Mn	175.21 Mn	-	-

Download Data